Pfizer said it will withdraw its sickle cell disease treatment Oxbryta from all markets worldwide, after data showed an ...

WeightWatchers said Friday that its CEO Sima Sistani, who shifted the weight loss giant’s strategy to prescribing obesity ...

The federal government renewed its threats to Johnson & Johnson on Friday over the company’s proposal to change how some ...

Baltimore's mayor and city council have sued Biogen, alleging that the Boston-based drug developer worked with pharmacy ...

What makes a great biotech startup? Every year, the Endpoints 11 awards try to answer that question. We've spent the last ...

Novo Nordisk has told government and global nonprofits that it plans to significantly downsize its manufacturing of some of ...

Johnson & Johnson and Legend Biotech's CAR-T cell therapy Carvykti reduced the risk of death by 45% compared to standard of ...

Travere Therapeutics said there is a “voluntary pause” in recruitment to its Phase 3 study in a rare, inherited disorder due ...

Cassava Sciences and two of its former executives have reached a resolution with the SEC over charges for “misleading” ...

The biggest drug driving Sanofi’s and Regeneron’s businesses is about to get a bit bigger. On Friday, the FDA approved ...

Biomedicines announced another pharma partnership Tuesday, agreeing to work on several protein therapies with the Swiss ...

Johnson & Johnson is winding down its pharma division's cardiovascular and metabolic unit, Endpoints News has learned. The ...